ApoE distribution and family history in genetic prion diseases in Germany

Journal of Molecular Neuroscience

Volumn 34, Issue 1, 2008, Pages 45-50

  Krasnianski, Anna ^a   Von Ahsen, Nicolas ^a   Heinemann, Uta ^a   Meissner, Bettina ^a   Kretzschmar, Hans A ^b   Armstrong, Victor W ^a   Zerr, Inga ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

ApoE; CJD; Codon 129 genotype; Dementia; PRNP

Indexed keywords

APOLIPOPROTEIN E; PRION PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CODON; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DEMENTIA; DISEASE COURSE; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC POLYMORPHISM; GENOTYPE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRION DISEASE; PROTEIN LOCALIZATION; RISK FACTOR; STRUCTURED QUESTIONNAIRE;

AGED; AGED, 80 AND OVER; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BRAIN CHEMISTRY; CODON; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; GERMANY; HUMANS; MALE; MIDDLE AGED; MUTATION; PREVALENCE; PRION DISEASES; PRIONS; RISK FACTORS;

EID: 40749087652     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-007-9001-2     Document Type: Article

References (30)

1. Alpérovitch, A., Zerr, I., Pocchiari, M., et al. (1999). Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet, 353, 1673-1674.
2. Amouyel, P., Vidal, O., Launay, J. M., & Laplanche, J. L. (1994). The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. The French research group on epidemiology of human spongiform encephalopathies. Lancet, 344, 1315-1318.
3. Chapman, J., Cervenakova, L., Petersen, R. B., et al. (1998). APOE in non-Alzheimer amyloidoses: Transmissible spongiform encephalopathies. Neurology, 51, 548-553.
4. Corder, E. H., Saunders, A. M., Risch, N. J., et al. (1994). Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genetics, 7, 180-184.
5. Corder, E. H., Saunders, A. M., Strittmatter, W. J., et al. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261, 921-923.
6. Davidson, Y., Gibbons, L., Purandare, N., et al. (2006). Apolipoprotein E epsilon4 allele frequency in vascular dementia. Dementia and Geriatric Cognitive Disorders, 22, 15-19.
7. Del Bo, R., Scarlato, M., Ghezzi, S., et al. (2006). Is M129V of PRNP gene associated with Alzheimer's disease? A case-control study and a meta-analysis. Neurobiology of Aging, 27, 770.e1-770.e5.
8. Gerdes, L. U., Klausen, I. C., Sihm, I., & Faergeman, O. (1992). Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genetic Epidemiology, 9, 155-167.
9. Goldfarb, L. G., Brown, P., & Gajdusek, D. C. (1992).The molecular genetics of human transmissible spongiform encephalopathy. In S. B. Prusiner, J. Collinge, J. Powell, & B. Anderton (Ed.), Prion diseases of human and animals (pp. 139-153).
10. Huang, Y. (2006). Apolipoprotein E and Alzheimer disease. Neurology, 66, S79-S85.
11. Kitamoto, T, Shin, R. W., Doh-Ura, K., et al. (1992). Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. American Journal of Pathology, 140, 1285-1294.
12. Kovacs, G. G., Puopolo, M., Ladogana, A., et al. (2005). Genetic prion disease: the EUROCJD experience. Human Genetics, 118, 166-174.
13. Kovács, G. G., Trabattoni, G., Hainfellner, J. A., Ironside, J. W., Knight, R. S., & Budka, H. (2002). Mutations of the prion protein gene. Phenotypic spectrum. Journal of Neurology, 249, 1567-1582.
14. Kretzschmar, H. A., Ironside, J. W., DeArmond, S. J., & Tateishi, J. (1996). Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Archives of Neurology, 53, 913-920.
15. Ladogana, A., Puopolo, M., Croes, E. A., et al. (2005). Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology, 64, 1586-1591.
16. Mastrianni, J. A., Iannicola, C., Myers, R. M., DeArmond, S., & Prusiner, S. B. (1996). Mutation of the prion protein gene at codon 208 in familial Creutzfeldt-Jakob disease. Neurology, 47, 1305-1312.
17. Mollenhauer, B., Trenkwalder, C., von Ahsen, N., et al. (2006) Beta-amyloid 1-42 and tau-protein in cerebrospinal fluid of patients with Parkinson's disease dementia. Dementia and Geriatric Disorders, 22, 200-208.
18. Nakagawa, Y., Kitamoto, T., Furukawa, H., Ogomori, K., & Tateishi, J. (1995). Allelic variation of apolipoprotein E in Japanese sporadic Creutzfeldt-Jakob disease patients. Neuroscience Letters, 187, 209-211.
19. O'Brien, J., Ames, D., & Burns, A. (2000). Dementia. London: Arnold.
20. Palmer, M. S., Dryden, A. J., Hughes, J. T., & Collinge, J. (1991). Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease [published erratum appears in Nature 1991 Aug 8;352(6335):547] [see comments]. Nature, 352, 340-342.
21. Raymond, M., & Rousset, F. (1995). Population genetics software for exact tests and ecumenicism. Journal of Heredity, 86, 248-249.
22. Salvatore, M., Seeber, A. C., Nacmias, B., et al. (1995). Apolipoprotein E in sporadic and familial Creutzfeldt-Jakob disease. Neuroscience Letters, 199, 95-98.
23. Saunders, A. M., Schmader, K., Breitner, J. C., et al. (1993). Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases [see comments]. Lancet, 342, 710-711.
24. Schulz-Schaeffer, W. J., Tschoke, S., Kranefuss, N., et al. (2000). The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases. American Journal of Pathology, 156, 51-56.
25. Van Everbroeck, B., Green, A., Pals, P., Martin, J. J., & Cras, P. (1999). Decreased levels of amyloid-beta 1-42 in cerebrospinal fluid of Creutzfeldt-Jakob disease patients. Journal of Alzheimers Disease, 1, 419-424.
26. WHO (1998). Human transmissible spongiform encephalopathies. Weekly Epidemiological Record, 47, 361-365.
27. Zannis, V. I., Just, P. W., & Breslow, J. L. (1981). Human apolipoprotein E isoprotein subclasses are genetically determined. American Journal of Human Genetics, 33, 11-24.
28. Zarranz, J. J., Digon, A., Atares, B., et al. (2005). Phenotypic variability in familial prion diseases due to the D178N mutation. Journal of Neurology, Neurosurgery and Psychiatry, 76, 1491-1496.
29. Zerr, I., Helmhold, M., Poser, S., Armstrong, V. W., & Weber, T. (1996). Apolipoprotein E phenotype frequency and cerebrospinal fluid concentration are not associated with Creutzfeldt-Jakob disease. Archives of Neurology, 53, 1233-1238.
30. Zerr, I., Pocchiari, M., Collins, S., et al. (2000). Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology, 55, 811-815.